2009 - Molecular and Cellular aspects of Chronic Lung Disease

This workshop brought together experts using different animal models of lung pathology, letting them interact with young researchers in the field. Through a combination of lectures and group discussions on selected topics gave researchers better access to related technology and experience.

The purpose of this exercise was to generate synergy from the combined experience, which should lead towards:

Consensus protocols for the study of lung disease in animal models
An investigation of common mechanisms in different forms of chronic lung disease
Novel and combined approaches in the field of experimental lung disease

2009 - Molecular and Cellular aspects of Chronic Lung Disease

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Cystic Fibrosis Lung disease, from animal models to experimental therapeutics.

B. Scholte (Rotterdam, The Netherlands)

Accompanying documents

Lung Embryology, congenital abnormalities

R. Rottier (Rotterdam, Netherlands)

Accompanying documents

Characterisation of a model that mimics aspects of the hyper-inflammatory response observed during an acute exacerbation of COPD.

K. Banner (Horsham, United Kingdom)

Accompanying documents

CFTR correctors and potentiators: pre-clinical studies in mouse models for CF

M. Wilke (Rotterdam, Netherlands)

Accompanying documents

Non-viral and viral gene transfer in ex vivo and in vivo lung models

U. Griesenbach (London, United Kingdom)

Accompanying documents

The inhibitory effect of fenretinide on the expression of inflammatory cytokines, possible molecular target of the drug and its relevance to cystic fibrosis.

D. Radzioch (Montreal, Canada)

Accompanying documents

From Electrophysiology to Pathology

D. Sheppard, (Bristol, United Kingdom)

Accompanying documents

Noninvasive and invasive pulmonary function measurements in mice with obstructive and restrictive respiratory diseases

W. Janssens (Leuven, Belgium)

Accompanying documents

Procoagulant activity and signalling in fibroproliferative lung disease

R. Chambers (London, United Kingdom)

Accompanying documents

A Transcriptional Network Controlling Normal Goblet Cell Differentiation and Mucous Production

J. Whitsett (Cincinnati, Oh, United States of America)

Accompanying documents

Effects of acute and chronic LPS exposure on the inflammatory response in CF mice

M. Egan (New Haven, Ct, United States of America)

Accompanying documents

Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin

T. Leal (Brussels, Belgium)

Accompanying documents

Chronic Airway Inflammation promotes de novo Sensitization to Inhaled Allergen by Persistent Activation of Dendritic Cells

L. Van Rijt (Amsterdam , Netherlands)

Accompanying documents

Use of Airway Epithelial Cell Cultures in Inflammatory Lung Disease Research

P. Hiemstra (Leiden, The Netherlands)

Accompanying documents

Phenotypic Analysis of a Ferret Model of Cystic Fibrosis

J. Engelhardt (Iowa City, Il, United States of America)

Accompanying documents

Chronic epithelial injury in Diffuse Parenchymal Lung Diseases (DPLD) cellular consequences and therapeutic prospects

A. Guenther (Giessen, Germany)

Accompanying documents

Potential therapeutic use of 12-Lipoxygenase inhibitors in the treatment of mucus overproduction in cystic fibrosis

L. Touqui (Paris, France)

Accompanying documents

2009 - Molecular and Cellular aspects of Chronic Lung Disease

2009 - Molecular and Cellular aspects of Chronic Lung Disease

#{title}